Evidence map›Paper›PMID 29589208›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020

Significance of

Ryogo Minamimoto, Toru Awaya, Kentaro Iwama, Masatoshi Hotta, Kazuhiko Nakajima, Risen Hirai, Osamu Okazaki, Yukio Hiroi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. LV functional evaluation onJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  5. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2023
    Article
  6. Independent Prognostic Utility ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  7. A Narrative Review ofBiomedicines · 2022
    Review
  8. Article
  9. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Review
  10. Article
  11. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  12. The evolving landscape of nuclear imaging in cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  13. Cardiac amyloidosis: A new challenge of multimodality imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ryogo MinamimotoDivision of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjyuku-ku, Tokyo, 162-8655, Japan. ryogominamimoto@yahoo.co.jp.
Toru AwayaDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Kentaro IwamaDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Masatoshi HottaDivision of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjyuku-ku, Tokyo, 162-8655, Japan.
Kazuhiko NakajimaDivision of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjyuku-ku, Tokyo, 162-8655, Japan.
Risen HiraiDivision of Hematology, Internal medicine, Tokyo Kita Medical Center, Tokyo, Japan.
Osamu OkazakiDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Yukio HiroiDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
National Center for Global Health and Medicine · JPTokyo-Kita Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was to investigate the significance of

methodsThirteen consecutive patients with suspected cardiac amyloidosis were considered for enrolment in this prospective pilot study. Participants were scheduled to undergo a series of

resultsSix of the 9 patients who underwent both imaging modalities were diagnosed with amyloidosis, of whom 3 patients were diagnosed with cardiac amyloidosis from endomyocardial biopsy. These 3 patients with positive

conclusionIn a small sample of subjects, the present study showed that

Indexed as

Aniline CompoundsAprotininCarbon RadioisotopesOrganotechnetium CompoundsPositron Emission Tomography Computed TomographyThiazolesAgedAged, 80 and overAmyloidosisFemaleHeart DiseasesHumansMaleMiddle AgedPilot ProjectsPredictive Value of Tests2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAniline CompoundsAprotininCarbon-11Carbon RadioisotopesOrganotechnetium Compoundstechnetium Tc 99m aprotininThiazolesAmyloidosisAprotininPittsburgh compound B

Identifiers

PMID29589208
OpenAlexW2794444062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.